1,3,4,6-Tetra-O-acetyl-2-deoxy-2-phthalimido-beta-D-glucopyranose>97.0%(HPLC)5g

Piperazine, 1-[2-(3,4-dimethoxyphenyl)ethyl]-4-(3-phenylpropyl)-, hydrochloride (1:2), 98%, 10mg

(Z)-2-(2-((tert-Butoxycarbonyl)amino)thiazol-4-yl)pent-2-enoic acid, 95.0%, 25g

Ethyl 2,5-dibromothiophene-3-carboxylate, 95.0%, 1g

(4S,4'S)-2,2'-[2-PHENYL-1-(PHENYLMETHYL)ETHYLIDENE]BIS[4-(1-METHYLETHYL)-4,5-DIHYDROOXAZOLE, 95%, 250mg

6-Aminonicotinic acid, 95.0%, 500g

2-[1-(methylamino)ethyl]phenol hydrochloride, 95%, 250mg

4-Methyl-1,5,6,7-tetrahydro-2H-cyclopenta[b]-pyridin-2-one, 95.0%, 5g

5-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole, 95%, 1g

6-methyl-2-(methylsulfanyl)-3,4-dihydropyrimidin-4-one, 98%, 25g

4-(Trifluoromethylthio)phenylacetic acid, 98.0%, 10g

Tris(2-ethylhexyl) 4,4',4''-((1,3,5-triazine-2,4,6-triyl)tris(azanediyl))tribenzoate, 97.0%, 100mg

[(3-fluorophenyl)methyl](2-methylpropyl)amine, 95.0%, 2g